Huahai Pharmaceutical announced that the company plans to jointly increase the capital of Huahai Tianheng with Wang Jingyi and Yunshu Tianheng by a total of 597 million yuan, of which the company will invest 197 million yuan and subscribe for 184 million additional shares. After the capital increase is completed, the company holds 33% of Huahai Tianheng's shares unchanged. The price of this capital increase is 1.0696 yuan/share. The investment method is cash. The funding source is own capital, and the capital increase is paid in two installments. Huahai Tianheng is an affiliated legal entity of the company. This transaction constitutes a related transaction and does not constitute a major asset restructuring. It has been reviewed and approved by the company's board of directors, and there is no need to submit it to the shareholders' meeting for review.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.